Pharmaceutical formulation for extended release

Details for Australian Patent Application No. 2008291920 (hide)

Owner AstraZeneca AB

Inventors Nilsson, Susanne Anette; Cullberg, Marie Christine Sindeby; Abrahamsson, Bertil Sven Inge; Hjartstam, Lars Johan Pontus de Verdier; Bagger-Jorgensen, Hakan Lars; Abrahmsen Alami, Susanna Johanna

Agent Davies Collison Cave

Pub. Number AU-A-2008291920

PCT Pub. Number WO2009/027745

Priority 60/969,188 31.08.07 US

Filing date 29 August 2008

Wipo publication date 5 March 2009

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/027745 Priority application(s): WO2009/027745

30 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008291921-Heterocyclic amides useful for the treatment of cancer and psoriasis

2008291905-Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(ADP-ribose)polymerase (PARP)